期刊文献+

抗肿瘤药紫杉醇的不良反应及临床应用 被引量:6

antineoplastic agent Paclitaxel adverse reaction and Clinical application
下载PDF
导出
摘要 目的探讨抗肿瘤药紫杉醇的不良反应及临床应用,为临床合理用药、防范不良反应提供参考。方法对60例发生紫杉醇不良反应的患者进行回顾性分析。结果紫杉醇的主要不良反应包括过敏反应、骨髓抑制、心脏毒性反应、胃肠道反应、肝脏毒性反应、神经毒性反应、癫痫大发作及水肿等。结论在使用抗肿瘤药物紫杉醇时应严加关注,采取积极措施有效预防不良反应的发生。 Objective Discusses antineoplastic agent Paclitaxel adverse reaction and Clinical application, for the clinical reasonable medication, guards against adverse reaction to provide the reference. Methods Has the Paclitaxel adverse reaction patient to 60 examples to carry on the review analysis.Results Paclitaxel main adverse reaction including an allergic reaction, arrest of bone marrow, Cardiotoxicity, Gastroduodenal, Hepatotoxicity, the nerve toxicity responds Neurotoxicity, the epilepsy big outbreak and dropsy and so on. Conclusion When uses antineoplastic agent Paclitaxel should strictly pay attention, takes the positive measure to prevent adverse reaction effectively the occurrence.
作者 刘延江
出处 《中国中医药咨讯》 2011年第19期36-37,共2页
关键词 紫杉醇 不良反应 临床应用 Paclitaxel adverse reaction Clinical application
  • 相关文献

参考文献3

二级参考文献41

  • 1滕小玉,管忠震,姚志文,刘冬耕,周宁宁,罗汉钰,Michael Hawkins,Patrick Soon-Shiong.晚期实体癌患者对不含聚氧乙烯蓖麻油注射用紫杉醇白蛋白纳米粒悬浮液的临床耐受性研究[J].癌症,2004,23(z1):1431-1436. 被引量:39
  • 2张仲苗.抗肿瘤药的神经毒性[J].国外医药(合成药.生化药.制剂分册),1995,16(4):230-234. 被引量:5
  • 3[1]1Wani MC,Taylor HL,Wall ME,et al.Plant antitumor agents.Ⅵ.The isolation and structure of taxol,a novel antileukemic and antitumor agent from Taxus brevifolia.J Am Chem Soc,1971,93 (9):2325
  • 4[2]Schiff PB,Fant J,Horwitz SB.Promotion of microtubule assembly in vitro by taxol.Nature,1979,277 (5698):665
  • 5[3]Horwitz SB.Mechanism of action of taxol.Trends Pharmacol Sci,1992,13 (4):134
  • 6[4]Stierle A,Strobel G,Stierle D,et al.The search for a taxol -producing microorganism among the endophytic fungi of the Pacific yew,Taxus brevifolia.J Nat Prod,1995,58(9):1315
  • 7[5]Byrd CA,Bornmann W,Erdjument-Bromage H,et al.Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide.Proc Natl Acad Sci U S A,1999,96 (10):5645
  • 8[6]Srivastava RK,Sasaki CY,Hardwick JM,et al.Bcl -2 -mediated drug resistance:Inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.J Exp Med,1999,190 (2):253
  • 9[7]Weiss RB,Donehower RC,Wiernik PH,et al.Hypersensitivity reactions from taxol.J Clin Oncol,1990,8 (7):1263
  • 10[8]ten Tije AJ,Verweij J,Loos WJ,et al.Pharmacological effects of formulation vehicles:implications for cancer chemotherapy.Clin Pharmacokinet,2003,42 (7):665

共引文献75

同被引文献39

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部